INBS
Intelligent Bio Solutions Inc (INBS)
Healthcare • NASDAQ • $2.36+3.06%
- Symbol
- INBS
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $2.36
- Daily Change
- +3.06%
- Market Cap
- $5.14M
- Trailing P/E
- N/A
- Forward P/E
- 6.74
- 52W High
- $24.90
- 52W Low
- $2.27
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 4.24
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
Company websiteResearch INBS on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.